Meeting News

Adverum reports significant progress with intravitreal gene therapy program

January 17, 2020
Adverum Biotechnologies has made significant progress in its lead clinical program for intravitreal gene therapy for retinal diseases, Leone

Phase 3 trial to investigate Port Delivery System in DME

January 17, 2020
Genentech and Roche initiated a phase 3 clinical trial to investigate the Port Delivery System with ranibizumab to treat patients with diabetic…

Meeting News

Glaukos leverages acquisitions to enter new ophthalmology spaces

January 16, 2020
With recent acquisitions, Glaukos now has multiple products in development that expand its reach outside of the glaucoma space and into more…

First US patient implanted with wireless retinal device

January 16, 2020
A surgeon at the UPMC Eye Center has implanted the first patient in the United States with a wireless retinal device to restore partial sight to…

In the Journals

Ocular changes differ in ground-based analogue of weightlessness

January 15, 2020
Subjects who underwent a ground-based analogue of weightlessness experienced greater peripapillary total retinal thickness but less choroidal…

BLOG: Can we achieve a kinder, gentler membrane peel in vitreoretinal surgery?

January 14, 2020
We perform membrane peeling in a variety of surgical cases: during epiretinal membrane removal, for macular hole closure and in the repair of a…

Iveric plans design of new Zimura trial

January 14, 2020
Iveric bio announced the design of a second pivotal trial for Zimura, a complement C5 inhibitor in development for the treatment of geographic…

Steroid administration to change in next cohorts of Adverum’s OPTIC trial

January 13, 2020
Adverum Biotechnologies will change how patients receive steroids to manage inflammation in the third and fourth cohorts of its phase 1 OPTIC trial…

ICYMI: Last week’s leading headlines

January 12, 2020
Keep up to date with the big news in ophthalmology. Here are some important stories you might have missed on from the past week:

In the JournalsPerspective

Ranibizumab treat-and-extend as effective as monthly injections in wet AMD

January 10, 2020
The CANTREAT trial found a treat-and-extend strategy with ranibizumab for patients with neovascular age-related macular degeneration was not worse…

AGTC’s retinitis pigmentosa gene therapy candidate shows positive 6-month results

January 10, 2020
An adeno-associated virus-based gene therapy improved visual function in patients with X-linked retinitis pigmentosa 6 months after dosing, Applied…


CPT codes available for Notal Vision’s home OCT system

January 9, 2020
Three new Category III codes have been established for Notal Vision’s home OCT system by the American Medical Association’s CPT Editorial…


What is your treatment process when a lifesaving therapy results in worsening ocular symptoms?

Ocular Surgery News U.S. Edition, January 25, 2020
As a retina specialist, my busy private practice sees a wide spectrum of the patient population. We have a significant number of patients on…

Cover Story

Systemic drugs and their ocular symptoms can complicate treatment

Ocular Surgery News U.S. Edition, January 25, 2020
Drugs that treat systemic diseases can be lifesaving, but when these drugs lead to poor ocular health or vision, the treatment paradigms can be…

Endoscopy-assisted PPV improves retinal reattachment rate after silicone oil removal

Ocular Surgery News U.S. Edition, January 25, 2020
More than 96% of patients who underwent endoscopy-assisted pars plana vitrectomy for silicone oil removal after proliferative…

Lindstrom's Perspective

Close monitoring needed to avoid drug-induced ocular side effects

Ocular Surgery News U.S. Edition, January 25, 2020
Richard L. Lindstrom, MD
Drug-induced ocular side effects are common in every ophthalmologist’s practice. When we review our senior patients’ lists of medicines…

Advances in imaging technology assist in early detection of diabetic retinopathy

Ocular Surgery News U.S. Edition, January 25, 2020
Karen Jeng-Miller, MD
Diabetic retinopathy is a leading cause of preventable blindness in working-aged adults. Risk factors for visually significant DR include duration of…


BLOG: Counting down the highlights from the world of retina 2019

January 7, 2020
That’s a wrap for 2019 — an exciting year of research and innovation in medical and surgical retina. As the associate editor for the…

Oxurion’s DME therapy shows positive phase 1 results

January 7, 2020
THR-687, a diabetic macular edema treatment candidate, was shown to be safe and well tolerated in a phase 1 trial, Oxurion announced in a press…

Ophthalmology’s top five FDA approvals of 2019

January 3, 2020
Ophthalmology’s armamentarium in the United States grew in 2019 with FDA approvals in retina and glaucoma treatment, as well as an approval for…